Bausch Health - Solta Medical Files Registration Statement for Proposed IPO

 Bausch Health Companies Inc. (NYSE/TSX: BHC) ('Bausch Health' or the 'Company') announced that its wholly owned subsidiary, Solta Medical Corporation ('Solta'), has publicly filed a registration statement on Form S-1 (the 'Registration Statement') with the U.S. Securities and Exchange Commission (the 'SEC') relating to a proposed initial public offering ('IPO') of Solta's common shares. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Solta has applied to list its common shares on the Nasdaq Global Select Market under the symbol 'SLTA.'

Bausch Health has completed all internal procedural steps and is fully prepared to launch both the Solta and Bausch + Lomb Corporation IPOs, subject to receipt of regulatory, stock exchange and other approvals. The Company is actively monitoring market conditions to determine the paths forward.

Goldman Sachs & Co. LLC and Morgan Stanley are acting as joint lead book-running managers for the proposed offering. Citigroup, Guggenheim Securities, Barclays and Evercore ISI are acting as joint book-running managers for the proposed offering.

https://www.marketscreener.com/quote/stock/BAUSCH-HEALTH-COMPANIES-I-44965075/news/Bausch-Health-Companies-Solta-Medical-Corporation-Files-Registration-Statement-for-Proposed-Initia-37826323/